- Direction
- Stable
- Own history
- —
- Peers
- 65th
- Persistence
- TRANSIENT
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTNovoCure Ltd's latest supported as-filed period reports revenue of $193.4M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 3.58% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 11.72% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 15.67% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 21.00% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 76.98% · CORE
Level · gp.fundamentals.operating_margin
Raw value -3.19% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 15.6%; Operating margin moved 1913 bp higher; Operating income increased 73.3%.
3 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 15.7%; Operating margin moved 1835 bp higher; Operating income increased 82.9%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 26.1%; Capex / revenue moved 31 bp higher.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 22.4%; Capex / revenue moved 20 bp higher.
2 evidence-backed componentsCurrent assets changed -43.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
NVCR · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001645113-26-000081SEC ↗10-QOct 29, 2026Period Sep 30, 20260001645113-26-000080SEC ↗8-KOct 1, 2026Period Oct 1, 20260001645113-26-000071SEC ↗8-KSep 9, 2026Period Sep 2, 20260001645113-26-000068SEC ↗8-KSep 1, 2026Period Sep 1, 20260001645113-26-000065SEC ↗8-KJul 23, 2026Period Jul 23, 20260001645113-26-000063SEC ↗10-QJul 23, 2026Period Jun 30, 20260001645113-26-000062SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 30, 2026Filed Jul 1, 2026 | Puri Michal NathChief Human Resources Officer | Grant Or AwardDirect | 1,905 | $11 | $21,241 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 30.04% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 9.04% · OPTIONAL
Total assets changed -39.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +27.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +100.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +73.3% from the comparable as-filed period.
Operating income changed +82.9% from the comparable as-filed period.
Total assets changed -36.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-09-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001997032-26-000006